| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-066414 |
| cik | 1835597 |
| name | PEPGEN INC. |
| sic | 2834 |
| countryba | US |
| stprba | MA |
| cityba | BOSTON |
| zipba | 02210 |
| bas1 | 1 MARINA PARK DRIVE, SUITE 900 |
| bas2 | |
| baph | 703-456-8000 |
| countryma | US |
| stprma | MA |
| cityma | BOSTON |
| zipma | 02210 |
| mas1 | 1 MARINA PARK DRIVE, SUITE 900 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 08:00:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | pepg-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-066414 | 20241231 | Additional Paid In Capital Common Stock | 390057000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Accounts Payable Current | 1752000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Accounts Payable Current | 2699000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 696000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Assets Current | 123761000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Assets Current | 101047000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Cash And Cash Equivalents At Carrying Value | 43633000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 50969000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Earnings Per Share Basic | -0.6300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | General And Administrative Expense | 492000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Facility Related And Other; | ||
| 0000950170-25-066414 | 20250331 | General And Administrative Expense | 5943000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Investment Income Interest | 1735000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Investment Income Interest | 1122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Net Cash Provided By Used In Operating Activities | -22930000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Noncash Merger Related Costs | 11000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Operating Income Loss | -19798000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Operating Lease Liability Current | 3117000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -44000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240131 | Payments Of Stock Issuance Costs | 3700000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Follow On Offering; | ||
| 0000950170-25-066414 | 20240331 | Payments Of Stock Issuance Costs | 100000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Sales Agreement; | ||
| 0000950170-25-066414 | 20250331 | Payments To Acquire Property Plant And Equipment | 125000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Prepaid Expense And Other Assets Current | 3570000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Proceeds From Issuance Initial Public Offering | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 3416000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Direct Research And Development Expenses; Product Or Service= P G N- E D O51; | ||
| 0000950170-25-066414 | 20231231 | Shares Outstanding | 23823241.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20231231 | Stockholders Equity | 108421000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20231231 | Stockholders Equity | 34000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20231231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240331 | Stockholders Equity | -37000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20241231 | Stockholders Equity | 118620000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Stockholders Equity | 91805000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 32674720.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Additional Paid In Capital Common Stock | 393489000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 135402000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 53080000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -5788000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -30202000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Income Taxes Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Liabilities | 32263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Operating Lease Right Of Use Asset | 21432000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -51000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Payments Of Stock Issuance Costs | 3730000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-066414 | 20250331 | Payments To Acquire Marketable Securities | 6726000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 2859000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Direct Research And Development Expenses; Product Or Service= P G N- E D O51; | ||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 908000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Other Research And Development Expenses; | ||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 4908000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Personnel- Related Including Stock- Based Compensation; | ||
| 0000950170-25-066414 | 20250331 | Shares Outstanding | 32720943.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240331 | Stockholders Equity | 178999000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Stockholders Equity | -199502000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066414 | 20250331 | Stockholders Equity | 393489000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value New Issues | 9900000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= At The Market Sales Agreement; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 395000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 395000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20250331 | Proceeds From Stock Plans | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Property Plant And Equipment Net | 3716000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 516000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Accrued Liabilities Current | 14615000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3432000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3432000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20241231 | Assets | 150883000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066414 | 20240331 | Deferred Offering Costs In Accounts Payable And Accrued Expenses | 188000.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20250331 | General And Administrative Expense | 1891000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Other General And Administrative Expenses; | ||
| 0000950170-25-066414 | 20250331 | Increase Decrease In Operating Lease Liability | -758000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Liabilities Current | 16696000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Net Income Loss | -30202000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Nonoperating Income Expense | 1778000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Operating Income Loss | -31321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Other Assets Noncurrent | 426000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Other Nonoperating Income Expense | 43000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Restricted Cash Noncurrent | 1548000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Retained Earnings Accumulated Deficit | -301665000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Shares Outstanding | 32619663.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240331 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value New Issues | 76352000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-066414 | 20250331 | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 24000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Accrued Liabilities Current | 11850000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 23000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Cash And Cash Equivalents At Carrying Value | 133854000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Cash And Cash Equivalents At Carrying Value | 49421000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Increase Decrease In Operating Lease Liability | 336000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Net Cash Provided By Used In Financing Activities | 86967000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Net Cash Provided By Used In Investing Activities | -11292000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Other Assets Noncurrent | 426000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Proceeds From Issuance Initial Public Offering | 76878000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20230731 | Proceeds From Issuance Of Common Stock | 100000000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Stifel Nicolaus And Company; Subsidiary Sale Of Stock= At The Market Issuance Sales Agreement; | ||
| 0000950170-25-066414 | 20240331 | Proceeds From Issuance Of Common Stock | 9900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 1264000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Facility Related And Other; | ||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 1149000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Other Research And Development Expenses; | ||
| 0000950170-25-066414 | 20240331 | Restricted Cash | 1548000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Retained Earnings Accumulated Deficit | -271463000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Share Based Compensation | 2022000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240131 | Stock Issued During Period Shares New Issues | 7530000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Follow On Offering; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value New Issues | 9900000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Sales Agreement; | ||
| 0000950170-25-066414 | 20250331 | Amortization And Interest Accretion Related To Operating Leases | 937000.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20250331 | Assets | 127393000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Deferred Offering Costs In Accounts Payable And Accrued Expenses | 0.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20240331 | Depreciation | 376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Earnings Per Share Basic | -0.9200 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Earnings Per Share Diluted | -0.6300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | General And Administrative Expense | 2786000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Personnel- Related Including Stock- Based Compensation; | ||
| 0000950170-25-066414 | 20240331 | Increase Decrease In Accrued Liabilities | -6765000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Liabilities Current | 20431000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Marketable Securities Current | 54148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Net Income Loss | -18020000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Net Income Loss | -30202000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066414 | 20241231 | Operating Lease Liability Current | 3094000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Operating Lease Liability Noncurrent | 15157000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 18000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Property And Equipment Included In Accounts Payable And Accrued Expenses | 19000.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20250331 | Property And Equipment Included In Accounts Payable And Accrued Expenses | 64000.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20250331 | Property Plant And Equipment Net | 3506000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -22000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Amortization And Interest Accretion Related To Operating Leases | -135000.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 82322000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Common Stock Value | 3000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Comprehensive Income Net Of Tax | -18091000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Comprehensive Income Net Of Tax | -30247000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -63000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | General And Administrative Expense | 1788000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Other General And Administrative Expenses; | ||
| 0000950170-25-066414 | 20250331 | General And Administrative Expense | 457000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Facility Related And Other; | ||
| 0000950170-25-066414 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -18020000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Income Taxes Paid Net | 86000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Increase Decrease In Accounts Payable Trade | 943000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Increase Decrease In Prepaid Expenses Other | -304000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Liabilities | 35588000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Liabilities And Stockholders Equity | 127393000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Net Income Loss | -18020000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066414 | 20240331 | Noncash Merger Related Costs | 20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Operating Expenses | 19798000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Operating Expenses | 31321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Operating Lease Liability Noncurrent | 15567000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -51000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Prepaid Expense And Other Assets Current | 3266000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 431000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Platform And External; | ||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 25378000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 370000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Platform And External; | ||
| 0000950170-25-066414 | 20231231 | Stockholders Equity | -181482000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-066414 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 28656401.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Stock Issued During Period Shares Restricted Stock Units Vested | 101280.0000 | shares | 1 | 0000950170-25-066414 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2022000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2022000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20250331 | Common Stock Value | 3000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Earnings Per Share Diluted | -0.9200 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Marketable Securities Current | 70770000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Net Cash Provided By Used In Investing Activities | 17149000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Nonoperating Income Expense | 1119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -44000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -51000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -20000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20250331 | Payment Of Offering Costs | 0.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20240331 | Payments To Acquire Marketable Securities | 29239000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Payments To Acquire Property Plant And Equipment | 53000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 4093000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Direct Research And Development Expenses; Product Or Service= P G N- E D O D M1; | ||
| 0000950170-25-066414 | 20240331 | Shares Outstanding | 32389435.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20231231 | Stockholders Equity | 289867000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20240331 | Stockholders Equity | 378535000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20241231 | Stockholders Equity | 390057000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066414 | 20250331 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20250331 | Stockholders Equity | -301665000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Shares New Issues | 1000000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= At The Market Sales Agreement; | ||
| 0000950170-25-066414 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 28656401.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 45181000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066414 | 20250331 | Depreciation | 388000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | General And Administrative Expense | 5066000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | General And Administrative Expense | 3595000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Personnel- Related Including Stock- Based Compensation; | ||
| 0000950170-25-066414 | 20240331 | Increase Decrease In Accounts Payable Trade | 88000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Increase Decrease In Accrued Liabilities | 2711000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Increase Decrease In Prepaid Expenses Other | -62000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Liabilities And Stockholders Equity | 150883000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Net Cash Provided By Used In Operating Activities | -22532000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Operating Lease Right Of Use Asset | 20866000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -44000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20250331 | Other Nonoperating Income Expense | -3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Payment Of Offering Costs | 206000.0000 | USD | 1 | 0000950170-25-066414 | |||
| 0000950170-25-066414 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066414 | 20240331 | Proceeds From Stock Plans | 395000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 14732000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Restricted Cash | 1548000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Restricted Cash Noncurrent | 1548000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20250331 | Share Based Compensation | 3432000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066414 | 20241231 | Stockholders Equity | -271463000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Shares New Issues | 7530000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-066414 | 20240331 | Research And Development Expense | 1533000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Facility Related And Other; | ||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 11708000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Direct Research And Development Expenses; Product Or Service= P G N- E D O D M1; | ||
| 0000950170-25-066414 | 20250331 | Research And Development Expense | 7471000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Personnel- Related Including Stock- Based Compensation; | ||
| 0000950170-25-066414 | 20241231 | Stockholders Equity | 23000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20250331 | Stockholders Equity | -22000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-066414 | 20240131 | Stock Issued During Period Shares New Issues | 1000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Shares Sales Agreement; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 36194.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066414 | 20240331 | Stock Issued During Period Value New Issues | 76351000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-066414 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 32674720.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expenses, Other | Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Increase Decrease In Accounts Payable Trade | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Payment Of Offering Costs | 0000950170-25-066414 | 1 | 0 | monetary | D | C | Payment of Offering Costs | Payment of offering costs. |
| Deferred Offering Costs In Accounts Payable And Accrued Expenses | 0000950170-25-066414 | 1 | 0 | monetary | D | C | Deferred Offering Costs In Accounts Payable And Accrued Expenses | Deferred offering costs in accounts payable and accrued expenses. |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Property And Equipment Included In Accounts Payable And Accrued Expenses | 0000950170-25-066414 | 1 | 0 | monetary | D | C | Property and equipment included in accounts payable and accrued expenses | Property and equipment included in accounts payable and accrued expenses. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Amortization And Interest Accretion Related To Operating Leases | 0000950170-25-066414 | 1 | 0 | monetary | D | D | Amortization and Interest Accretion Related to Operating Leases | Amortization and interest accretion related to operating leases. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Proceeds From Issuance Initial Public Offering | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance Initial Public Offering | The cash inflow associated with the amount received from entity's first offering of stock to the public. |
| Restricted Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Proceeds From Stock Plans | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Plans | The cash inflow associated with the amount received from the stock plan during the period. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Stock Issued During Period Shares Restricted Stock Units Vested | 0000950170-25-066414 | 1 | 0 | shares | D | Stock Issued During Period Shares Restricted Stock Units Vested | Stock issued during period, shares, restricted stock units vested. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Noncash Merger Related Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Noncash Merger Related Costs | Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale | Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-066414 | 2 | 4 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-066414 | 2 | 5 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Marketable securities | 0 |
| 0000950170-25-066414 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-066414 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-066414 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-066414 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset | 0 |
| 0000950170-25-066414 | 2 | 10 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-066414 | 2 | 11 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-066414 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-066414 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-066414 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0000950170-25-066414 | 2 | 17 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability | 0 |
| 0000950170-25-066414 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-066414 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, net of current portion | 0 |
| 0000950170-25-066414 | 2 | 20 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-066414 | 2 | 21 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 7) | 0 |
| 0000950170-25-066414 | 2 | 23 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock | 0 |
| 0000950170-25-066414 | 2 | 24 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock | 0 |
| 0000950170-25-066414 | 2 | 25 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-066414 | 2 | 26 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive (loss) income | 0 |
| 0000950170-25-066414 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-066414 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-066414 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-066414 | 3 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-066414 | 3 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-066414 | 3 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-066414 | 3 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0000950170-25-066414 | 3 | 7 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0000950170-25-066414 | 3 | 8 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other (expense) income, net | 0 |
| 0000950170-25-066414 | 3 | 9 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
| 0000950170-25-066414 | 3 | 10 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net loss before income tax | 0 |
| 0000950170-25-066414 | 3 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-066414 | 3 | 12 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
| 0000950170-25-066414 | 3 | 13 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
| 0000950170-25-066414 | 3 | 14 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common stock outstanding, basic | 0 |
| 0000950170-25-066414 | 3 | 15 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common stock outstanding, diluted | 0 |
| 0000950170-25-066414 | 3 | 17 | IS | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Cumulative translation adjustment arising during the period | 0 |
| 0000950170-25-066414 | 3 | 18 | IS | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized (loss) on marketable securities | 0 |
| 0000950170-25-066414 | 3 | 19 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0000950170-25-066414 | 4 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-066414 | 4 | 14 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance, shares | 0 |
| 0000950170-25-066414 | 4 | 15 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock | 0 |
| 0000950170-25-066414 | 4 | 16 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock, Shares | 0 |
| 0000950170-25-066414 | 4 | 17 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Units Vested | 0000950170-25-066414 | Vesting of restricted stock units, Shares | 0 |
| 0000950170-25-066414 | 4 | 18 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0000950170-25-066414 | 4 | 19 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options, Shares | 0 |
| 0000950170-25-066414 | 4 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-066414 | 4 | 21 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized loss on marketable securities | 0 |
| 0000950170-25-066414 | 4 | 22 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Cumulative translation adjustment arising during the period | 0 |
| 0000950170-25-066414 | 4 | 23 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-066414 | 4 | 24 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-066414 | 4 | 25 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance, shares | 0 |
| 0000950170-25-066414 | 5 | 7 | EQ | 1 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Net of issuance costs | 0 |
| 0000950170-25-066414 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-066414 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0000950170-25-066414 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-066414 | 6 | 6 | CF | 0 | H | Amortization And Interest Accretion Related To Operating Leases | 0000950170-25-066414 | Amortization and interest accretion related to operating lease | 0 |
| 0000950170-25-066414 | 6 | 7 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Amortization and accretion of premium and discounts on marketable securities, net | 1 |
| 0000950170-25-066414 | 6 | 8 | CF | 0 | H | Noncash Merger Related Costs | us-gaap/2024 | Other non-cash adjustments | 0 |
| 0000950170-25-066414 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | Prepaids and other current and non-current assets | 1 |
| 0000950170-25-066414 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable Trade | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-066414 | 6 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses and other non-current liabilities | 0 |
| 0000950170-25-066414 | 6 | 13 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities, current and non-current | 0 |
| 0000950170-25-066414 | 6 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-066414 | 6 | 16 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-066414 | 6 | 17 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0000950170-25-066414 | 6 | 18 | CF | 0 | H | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | us-gaap/2024 | Maturities of marketable securities | 0 |
| 0000950170-25-066414 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
| 0000950170-25-066414 | 6 | 21 | CF | 0 | H | Proceeds From Issuance Initial Public Offering | us-gaap/2024 | Issuance of common stock in public offering, net of underwriters' fees | 0 |
| 0000950170-25-066414 | 6 | 22 | CF | 0 | H | Payment Of Offering Costs | 0000950170-25-066414 | Payment of offering costs | 1 |
| 0000950170-25-066414 | 6 | 23 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Issuance of common stock from At-the-Market Sales Agreement, net of underwriters' fees | 0 |
| 0000950170-25-066414 | 6 | 24 | CF | 0 | H | Proceeds From Stock Plans | us-gaap/2024 | Proceeds from employee equity plans | 0 |
| 0000950170-25-066414 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-066414 | 6 | 26 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash | 0 |
| 0000950170-25-066414 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash, cash equivalents and restricted cash | 0 |
| 0000950170-25-066414 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of period | 0 |
| 0000950170-25-066414 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
| 0000950170-25-066414 | 6 | 31 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-066414 | 6 | 32 | CF | 0 | H | Restricted Cash | us-gaap/2024 | Restricted Cash | 0 |
| 0000950170-25-066414 | 6 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Total cash, cash equivalents and restricted cash at end of period | 0 |
| 0000950170-25-066414 | 6 | 35 | CF | 0 | H | Property And Equipment Included In Accounts Payable And Accrued Expenses | 0000950170-25-066414 | Property and equipment included in accounts payable and accrued expenses | 0 |
| 0000950170-25-066414 | 6 | 36 | CF | 0 | H | Deferred Offering Costs In Accounts Payable And Accrued Expenses | 0000950170-25-066414 | Deferred offering costs in accounts payable and accrued expenses | 0 |
| 0000950170-25-066414 | 6 | 37 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for taxes | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |